• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,143
110
76
72
69

COUNTRY

71
22
16
10
9

CATEGORIES

  • 575
  • 121
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,047
1,293
2,049
3,059

PUBLISHED

79
253
695
3,059

PRODUCT TYPE

2,431
494
69
62
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Squamous Cell Carcinoma - Pipeline Review, H1 2013 Squamous Cell Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Review, H1 2013

Squamous Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Squamous Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Global Prostate Cancer Pipeline Capsule - 2013 Global Prostate Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Prostate Cancer Pipeline Capsule - 2013

Fore Pharma's latest report ‘Global Prostate Cancer Pipeline Capsule – 2013' provides up-to-date information on key Research and Development (R&D) activities in the global prostate cancer market It...

April 2013
FROM
Global Ovarian Cancer Pipeline Capsule - 2013 Global Ovarian Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Ovarian Cancer Pipeline Capsule - 2013

Fore Pharma's latest report ‘Global Ovarian Cancer Pipeline Capsule – 2013' provides up-to-date information on key Research and Development (R&D) activities in the global ovarian cancer market It covers...

April 2013
FROM
Global Head and Neck Cancer Pipeline Capsule - 2013 Global Head and Neck Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Head and Neck Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Head and Neck Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global head and neck cancer...

April 2013
FROM

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

April 2013
FROM
2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape - Product Thumbnail Image

2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test This comprehensive five-country report identifies...

April 2013
FROM

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

March 2013
FROM

EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022

EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022 Lung cancer is a disease of uncontrolled cell growth in the lung tissues It is one of the most commonly occurring cancers...

March 2013
FROM
Bone Cancer - Pipeline Review, H1 2013 Bone Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Bone Cancer - Pipeline Review, H1 2013

Bone Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bone Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Colon Carcinoma - Pipeline Review, H1 2013 Colon Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Colon Carcinoma - Pipeline Review, H1 2013

Colon Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colon Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

March 2013
FROM
Non-Hodgkin Lymphoma - Pipeline Review, H1 2013 Non-Hodgkin Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H1 2013

Non-Hodgkin Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Non-Hodgkin Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

March 2013
FROM
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2013 Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2013 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2013

Graft Versus Host Disease (GVHD) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2013', provides an overview of the indication’s...

March 2013
FROM
Hypertension - Pipeline Review, H1 2013 Hypertension - Pipeline Review, H1 2013 - Product Thumbnail Image

Hypertension - Pipeline Review, H1 2013

Hypertension – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hypertension - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Type 2 Diabetes - Pipeline Review, H1 2013 Type 2 Diabetes - Pipeline Review, H1 2013 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2013

Type 2 Diabetes – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Type 2 Diabetes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

March 2013
FROM
Multiple Sclerosis - Pipeline Review, H1 2013 Multiple Sclerosis - Pipeline Review, H1 2013 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2013

Multiple Sclerosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

March 2013
FROM
Overactive Bladder - Pipeline Review, H1 2013 Overactive Bladder - Pipeline Review, H1 2013 - Product Thumbnail Image

Overactive Bladder - Pipeline Review, H1 2013

Overactive Bladder – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Overactive Bladder - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

March 2013
FROM
Neutropenia - Pipeline Review, H1 2013 Neutropenia - Pipeline Review, H1 2013 - Product Thumbnail Image

Neutropenia - Pipeline Review, H1 2013

Neutropenia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neutropenia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Chronic Back Pain - Pipeline Review, H1 2013 Chronic Back Pain - Pipeline Review, H1 2013 - Product Thumbnail Image

Chronic Back Pain - Pipeline Review, H1 2013

Chronic Back Pain – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Chronic Back Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

March 2013
FROM
Diabetes - Pipeline Review, H1 2013 Diabetes - Pipeline Review, H1 2013 - Product Thumbnail Image

Diabetes - Pipeline Review, H1 2013

Diabetes – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

March 2013
FROM
Metastatic Melanoma - Pipeline Review, H1 2013 Metastatic Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H1 2013

Metastatic Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

March 2013
FROM
Loading Indicator

Our Clients

Our clients' logos